Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001209191-23-002179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-01-05 | 2023-01-04 | DNLI | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $28.73 | -5,029 | 2.21M | -0.2% | -$144.5K |
| D | 2023-01-05 | 2023-01-03 | DNLI | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +82.2K | 231.9K | +55% | $0 |
| D | 2023-01-05 | 2023-01-03 | DNLI | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +246.7K | 246.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | S | D | 5,029 | $28.73 | 2,213,464 | I | — | — | (F5) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.58 to $29.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F2) Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person. |
| 2 | Common | Common Stock | 2023-01-03 | A | A | 82,240 | $0.00 | 231,934 | D See footnote | — | — | (F1) Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. (F3) Includes 231,934 RSUs. (F2) Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person. (F6) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |
| 3 | Derivative | Stock Option (right to buy) | 2023-01-03 | A | A | 246,720 | $0.00 | 246,720 | D | $27.63 · — to 2033-01-02 | 246,720 Common Stock | (F7) 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. |